ArticleMikrochimica acta2026
Surfactant/β-cyclodextrin inclusion-mediated nucleic acid enrichment for ratiometric electrochemical sensing of low-abundance Staphylococcus aureus.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Staphylococcus aureus (S. aureus), one of the most prevalent foodborne pathogens, poses a persistent global threat to public health by causing severe infections and food poisoning. We present β-cyclodextrin/surfactant inclusion-mediated nucleic acid enrichment strategy synergized with a ratiometric electrochemical biosensor for the robust determination of S. aureus. Unlike commercial kits limited by dilution effects, our method utilizes cetyltrimethylammonium bromide (CTAB) to induce the condensation of nucleic acids from large-volume lysates, followed by a competitive inclusion reaction where β-cyclodextrin encapsulates the hydrophobic alkyl chains of CTAB. This mechanism triggers the efficient release of DNA into a micro-volume, achieving a ~ 12-fold enrichment. The enriched target is subsequently quantified using a ratiometric electrochemical interface equipped with methylene blue (MB) and ferrocene (Fc), where the current ratio (IMB/IFc) serves as an intrinsic self-calibration parameter to eliminate the internal/external disturbances. Under optimized experimental conditions, the developed biosensor demonstrated a wide linear range spanning from 10¹ to 107 CFU/mL, with a low limit of detection of 8 CFU/mL. Moreover, the biosensor achieved reliable quantification of S. aureus in complex real samples, including peach juice and UHT skim milk, confirming its practical applicability. This work establishes a novel and cost-effective electrochemical sensing strategy that couples DNA enrichment and release with ratiometric signal, providing a feasible technical approach for rapid pathogen detection.
Indexed as
Identifiers
42032325What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.